Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 2, Issue 3, 2010, Pages 149-157

  Rastmanesh, Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Attention deficit; Dopamine deficit theory; Drug development; Drug policy; Hyperactivity disorder; Nutrition; Planning bias; Treatment bias

Indexed keywords

ATOMOXETINE; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DOPAMINE; DOPAMINE TRANSPORTER; METHYLPHENIDATE; NORADRENALIN; SEROTONIN;

ACUTE DRUG ADMINISTRATION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDHOOD DISEASE; CHRONIC DRUG ADMINISTRATION; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG CONTROL; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HEALTH CARE POLICY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; NUTRITIONAL STATUS; OPPOSITIONAL DEFIANT DISORDER; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK ASSESSMENT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIAS (EPIDEMIOLOGY); CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOPAMINE; DRUG AND NARCOTIC CONTROL; DRUG DISCOVERY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NUTRITION DISORDERS; PREFRONTAL CORTEX; PSYCHOLOGICAL THEORY; SEROTONIN;

EID: 79958863327     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-010-0033-z     Document Type: Article

References (104)

1. Acosta MT, Rcos-Burgos M, Muenke M (2004) Attention deficit/hyperactivity disorder (ADHD): complex phenotype, simple genotype? Genet Med 6:1-15
2. Agrawal A, Scherrer JF, Grant JD, Sartor CE, Pergadia ML, Duncan AE, Madden PA, Haber JR, Jacob T, Bucholz KK, Xian H (2010) The effects of maternal smoking during pregnancy on offspring outcomes. Prev Med 50:13-18
3. Anderson GM, Dover MA, Yang BP, Holahan JM, Shaywitz SE, Marchione KE, Hall LM, Fletcher JM, Shaywitz BA (2000) Adrenomedullary function during cognitive testing in attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39:635-643
4. Arnold LE, Pinkham SM, Votolato N (2000) Does zinc moderate essential fatty acid and amphetamine treatment of attentiondeficit/ hyperactivity disorder? J Child Adolesc Psychopharmacol 10:111-117
5. Arnold LE, Bozzolo H, Hollway J, Cook A, DiSilvestro RA, Bozzolo DR, Crowl L, Ramadan Y, Williams C (2005) Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15:628-636
6. Arnsten AF (2006) Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 67 (Suppl 8):7-12
7. Arnsten AF (2009) Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23 (Suppl 1):33-41
8. Banaschewski T, Becker K, Scherag S, Franke B, Coghill D (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 19:237-257
9. Bellgrove MA, Mattingley JB (2008) Molecular genetics of attention. Ann N Y Acad Sci 1129:200-212
10. Bellgrove MA, Hawi Z, Gill M, Robertson IH (2006) The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex 42:838-845
11. Bellinger DC (2008) Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr 20:172-177
12. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV (2008) Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 165:597-603
13. Bol VV, Delattre AI, Reusens B, Raes M, Remacle C (2009) Forced catch-up growth after fetal protein restriction alters the adipose tissue gene expression program leading to obesity in adult mice. Am J Physiol Regul Integr Comp Physiol 297:R291-R299
14. Boulougouris V, Tsaltas E (2008) Serotonergic and dopaminergic modulation of attentional processes. Prog Brain Res 172:517-542
15. Bramstedt KA (2007) Caffeine use by children: the quest for enhancement. Subst Use Misuse 42:1237-1251
16. Broad RD, Wheeler K (2006) An adult with childhood medical trauma treated with psychoanalytic psychotherapy and EMDR: a case study. Perspect Psychiatr Care 42:95-105
17. Brookes KJ, Mill J, Guindalini C, Curran S, Xu X, Knight J, Chen CK, Huang YS, Sethna V, Taylor E, Chen W, Breen G, Asherson P (2006) A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 63:74-81
18. Castellanos FX (1997) Toward a pathophysiology of attention-deficit/ hyperactivity disorder. Clin Pediatr (Phila) 36:381-393
19. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL (1996) Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:607-616
20. Chen JH, Martin-Gronert MS, Tarry-Adkins J, Ozanne SE (2009) Maternal protein restriction affects postnatal growth and the expression of key proteins involved in lifespan regulation in mice. PLoS One 4:e4950
21. Cherkasova MV, Hechtman L (2009) Neuroimaging in attentiondeficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychiatry 54:651-664
22. Chudasama Y, Robbins TW (2004) Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 174:86-98
23. Colborn T (2004) Neurodevelopment and endocrine disruption. Environ Health Perspect 112:944-949
24. Colter AL, Cutler C, Meckling KA (2008) Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 7:8
25. Comings DE, Blum K (2000) Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 126:325-341
26. Comings DE, Gade-Andavolu R, Gonzalez N, Blake H, Wu S, MacMurray JP (1999) Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin Genet 55:160-172
27. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, Baker R, Dietz G, Saucier G, MacMurray JP (2000a) Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58:31-40
28. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Dietz G, Saucier G, MacMurray JP (2000b) Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57:178-196
29. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Mann MB, Dietz G, Saucier G, MacMurray JP (2000c) A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin Genet 58:375-385
30. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998
31. Cosgrove VE, Rhee SH, Gelhorn HL, Boeldt D, Corley RC, Ehringer MA, Young SE, and Hewitt JK (2010). Structure and etiology of co-occurring internalizing and externalizing disorders in adolescents. J Abnorm Child Psychol
32. D'Onofrio BM, Van Hulle CA, Waldman ID, Rodgers JL, Rathouz PJ, Lahey BB (2007) Causal inferences regarding prenatal alcohol exposure and childhood externalizing problems. Arch Gen Psychiatry 64:1296-1304
33. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attentiondeficit/ hyperactivity disorder. Biol Psychiatry 57:1313-1323
34. Feng Y, Wigg KG, Makkar R, Ickowicz A, Pathare T, Tannock R, Roberts W, Malone M, Kennedy JL, Schachar R, Barr CL (2005) Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 139B:1-6
35. Gonon F (2009) The dopaminergic hypothesis of attention-deficit/hyperactivity disorder needs re-examining. Trends Neurosci 32:2-8
36. Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD (2010) Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci 17:227-238
37. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26S-49S
38. Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA (2009) Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19:233-239
39. Habek D, Kovacevic M (2010) Adverse pregnancy outcomes and long-term morbidity after early fetal hypokinesia in maternal smoking pregnancies. Arch Gynecol Obstet
40. esslinger B, Tebartz van EL, Nyberg E, Dykierek P, Richter H, Berner M, Ebert D (2002) Psychotherapy of attention deficit hyperactivity disorder in adults-a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252:177-184
41. Hultman CM, Torrang A, Tuvblad C, Cnattingius S, Larsson JO, Lichtenstein P (2007) Birth weight and attention-deficit/hyperactivity symptoms in childhood and early adolescence: a prospective Swedish twin study. J Am Acad Child Adolesc Psychiatry 46:370-377
42. Johnson KA, Wiersema JR, Kuntsi J (2009a) What would Karl Popper say? Are current psychological theories of ADHD falsifiable? Behav Brain Funct 5:15
43. Johnson M, Ostlund S, Fransson G, Kadesjo B, Gillberg C (2009b) Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord 12:394-401
44. Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A (2006) Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 74:17-21
45. Kieling C, Genro JP, Hutz MH, Rohde LA (2008) The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet 147B:485-490
46. Koda K, Ago Y, Cong Y, Kita Y, Takuma K, and Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem
47. Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaim M, Mouren MC, Arnulf I (2008) Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38:20-26
48. Krisanaprakornkit T, Ngamjarus C, Witoonchart C, Piyavhatkul N (2010) Meditation therapies for attention-deficit/hyperactivity disorder (ADHD). Cochrane Database Syst Rev 6:CD006507
49. Kronenberg G, Ende G, Alm B, Deuschle M, Heuser I, Colla M (2008) Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci 258:446-450
50. Lahti J, Raikkonen K, Kajantie E, Heinonen K, Pesonen AK, Jarvenpaa AL, Strandberg T (2006) Small body size at birth and behavioural symptoms of ADHD in children aged five to six years. J Child Psychol Psychiatry 47:1167-1174
51. Li D, Sham PC, Owen MJ, He L (2006) Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15:2276-2284
52. Lindblad F, Hjern A (2010) ADHD after fetal exposure to maternal smoking. Nicotine Tob Res 12:408-415
53. Maher BS, Marazita ML, Ferrell RE, Vanyukov MM (2002) Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 12:207-215
54. Maziade M, Rouleau N, Lee B, Rogers A, Davis L, Dickson R (2009) Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study. J Child Adolesc Psychopharmacol 19:709-718
55. McCann JC, Ames BN (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 22:982-1001
56. McCann D, Barrett A, Cooper A, Crumpler D, Dalen L, Grimshaw K, Kitchin E, Lok K, Porteous L, Prince E, Sonuga-Barke E, Warner JO, Stevenson J (2007) Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet 370:1560-1567
57. Miller EK, Cohen JD (2001) An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24:167-202
58. Millichap JG (2008) Etiologic classification of attention-deficit/ hyperactivity disorder. Pediatrics 121:e358-e365
59. Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T (2007) Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 46:1028-1040
60. Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A (2006) Clinical review: evidence-based diagnosis and treatment of ADHD in children. Mo Med 103:617-621
61. Nigg JT (2005) Neuropsychologic theory and findings in attentiondeficit/ hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry 57:1424-1435
62. Nigg JT (2008) ADHD, lead exposure and prevention: how much lead or how much evidence is needed? Expert Rev Neurother 8:519-521
63. Nigg JT, Casey BJ (2005) An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol 17:785-806
64. Nikolaus S, Antke C, Muller HW (2009) In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders Behav Brain Res 204:32-66
65. Oades RD (2008) Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res 172:543-565
66. Pelsser LM, Buitelaar JK, Savelkoul HF (2009a) ADHD as a (non) allergic hypersensitivity disorder: a hypothesis. Pediatr Allergy Immunol 20:107-112
67. Pelsser LM, Frankena K, Toorman J, Savelkoul HF, Pereira RR, Buitelaar JK (2009b) Arandomised controlled trial into the effects of food on ADHD. Eur Child Adolesc Psychiatry 18:12-19
68. Pineda DA, Palacio LG, Puerta IC, Merchan V, Arango CP, Galvis AY, Gomez M, Aguirre DC, Lopera F, Rcos-Burgos. M (2007) Environmental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate. Eur Child Adolesc Psychiatry 16:337-346
69. Pliszka SR (2005) The neuropsychopharmacology of attention-deficit/ hyperactivity disorder. Biol Psychiatry 57:1385-1390
70. Ptacek R, Kuzelova H, Paclt I, Zukov I, Fischer S (2009) ADHD and growth: anthropometric changes in medicated and non-medicated ADHD boys. Med Sci Monit 15:CR595-CR599
71. Richardson AJ (2004) Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 70:383-390
72. Roman T, Rohde LA, Hutz MH (2004) Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. Am J Pharmacogenomics 4:83-92
73. Rommelse NN, Altink ME, Rias-Vasquez A, Buschgens CJ, Fliers E, Faraone SV, Buitelaar JK, Sergeant JA, Franke B, Oosterlaan J (2008) A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am J Med Genet B Neuropsychiatr Genet 147B:1536-1546
74. Root AW (2006) Endocrinology and metabolism 2006: editorial comments. Curr Opin Pediatr 18:423-426
75. Ruocco LA, Carnevale UA, Treno C, Sadile AG, Melisi D, Arra C, Ibba M, Schirru C, Carboni E (2010) Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats. Behav Brain Res 210:99-106
76. Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, Sagvolden T (2006) Response variability in Attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2:30
77. Sagvolden T, Johansen EB, Aase H, Russell VA (2005) A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28:397-419
78. Sanders AF (1983) Towards a model of stress and human performance. Acta Psychol (Amst) 53:61-97
79. Sanders AF, van Duren LL (1998) Stimulus control of visual fixation duration in a single saccade paradigm. Acta Psychol (Amst) 99:163-176
80. Schubiner H, Katragadda S (2008) Overview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 19:209-215 vii
81. Sergeant JA (2005) Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model. Biol Psychiatry 57:1248-1255
82. Sergeant JA, Geurts H, Huijbregts S, Scheres A, Oosterlaan J (2003) The top and the bottom of ADHD: a neuropsychological perspective. Neurosci Biobehav Rev 27:583-592
83. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Clasen L, Evans A, Giedd J, Rapoport JL (2007) Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 104:19649-19654
84. Slotkin TA, Wrench N, Ryde IT, Lassiter TL, Levin ED, Seidler FJ (2009) Neonatal parathion exposure disrupts serotonin and dopamine synaptic function in rat brain regions: modulation by a high-fat diet in adulthood. Neurotoxicol Teratol 31:390-399
85. Smith KM, Daly M, Fischer M, Yiannoutsos CT, Bauer L, Barkley R, Navia BA (2003) Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: genetic analysis of the Milwaukee longitudinal study. Am J Med Genet B Neuropsychiatr Genet 119B:77-85
86. Sonuga-Barke EJ (2002) Psychological heterogeneity in AD/HD-a dual pathway model of behaviour and cognition. Behav Brain Res 130:29-36
87. Sonuga-Barke EJ (2003) The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 27:593-604
88. Sonuga-Barke EJ (2005) Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57:1231-1238
89. Sonuga-Barke EJ, Taylor E, Sembi S, Smith J (1992) Hyperactivity and delay aversion-I. The effect of delay on choice. J Child Psychol Psychiatry 33:387-398
90. Sonuga-Barke EJ, Coghill D, Wigal T, DeBacker M, Swanson J (2009) Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control. J Child Adolesc Psychopharmacol 19:683-690
91. Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR (2003) Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm 9:416-423
92. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, Murias M, Moriarity J, Barr C, Smith M, Posner M (2000) Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21-25
93. Torrioli MG, Vernacotola S, Peruzzi L, Tabolacci E, Mila M, Militerni R, Musumeci S, Ramos FJ, Frontera M, Sorge G, Marzullo E, Romeo G, Vallee L, Veneselli E, Cocchi E, Garbarino E, Moscato U, Chiurazzi P, D'Iddio S, Calvani M, Neri G (2008) A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A 146:803-812
94. Tran TT, Chowanadisai W, Lonnerdal B, Le L, Parker M, Chicz-Demet A, Crinella FM (2002) Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive functions. Neurotoxicology 23:645-651
95. Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, Bodennec J (2008) Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr 87:1170-1180
96. van Straten EM, Bloks VW, Huijkman NC, Baller JF, Meer H, Lutjohann D, Kuipers F, Plosch T (2010) The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am J Physiol Regul Integr Comp Physiol 298:R275-R282
97. Volkow ND, Wang G, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding Y, Gatley SJ, Gifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21:RC121
98. Vucetic Z, Totoki K, Schoch H, Whitaker KW, Hill-Smith T, Lucki I, Reyes TM (2010) Early life protein restriction alters dopamine circuitry. Neuroscience 168:359-370
99. Wiersema R, van der Meere MJ, Roeyers H, Van CR, Baeyens D (2006) Event rate and event-related potentials in ADHD. J Child Psychol Psychiatry 47:560-567
100. Wilens TE, Spencer TJ, Biederman J (2002) A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 5:189-202
101. Williams J (2008) Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit. J Child Psychol Psychiatry 49:705-711
102. Williams J, Taylor E (2004) Dopamine appetite and cognitive impairment in attention deficit/hyperactivity disorder. Neural Plast 11:115-132
103. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY (2007) A metaanalysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 30-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 144B:541-550
104. Yaryura-Tobias JA, Rabinowitz DC, Neziroglu F (2003) Possible basal ganglia pathology in children with complex symptoms. J Clin Psychiatry 64:1495-1501